Nirupama Ramadas; Erica Sparkenbaugh/LinkedIn
Nov 3, 2025, 04:56
Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
RPTH Journal shared on LinkedIn:
”Sickle cell disease (SCD) is more than a hemoglobinopathy, it’s a chronic thrombo-inflammatory disorder.
This review from Nirupama Ramadas and Erica Sparkenbaugh explores how hemolysis, endothelial activation, and cellular aggregates drive thrombosis, organ injury, and inflammation, and what that means for future therapies.
Read more.”
Read the full article in RPTH.
Article: Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis
Authors: Nirupama Ramadas, Erica Sparkenbaugh
Stay updated on all scientific advances with Hemostasis Today.
-
May 18, 2026, 13:50Arshad-Ali Auhammad: Celebrating Youth Leadership in the Global Bleeding Disorders Community
-
May 18, 2026, 13:36Zain Khalpey: In Cardiovascular Medicine Flow Is Everything
-
May 18, 2026, 13:36George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
-
May 18, 2026, 13:33Astha Thakkar: Three Things to Know Before Your IV Iron Infusion
-
May 18, 2026, 13:29Brian O Mahony: Ahead of the World Health Assembly in Geneva
-
May 18, 2026, 13:24Marian Galovic: When, Why and How to Perform an EEG After Stroke?
-
May 18, 2026, 13:23Behnood Bikdeli: A Wonderful Experience at the International Symposium on Thrombosis and Vessels
-
May 18, 2026, 13:16Wolfgang Miesbach: New Editorial Highlights – 6 Year Outcomes of Hemophilia B Gene Therapy
-
May 18, 2026, 13:10Ritika Jankar: Hemophilia Market Size to Reach USD 23.46 Billion by 2035